Skip To Main Content
Deying Kang on Muck Rack

Deying Kang

As seen in: Nature, Frontiers, Respiratory Medicine
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Deying

Contact Deying, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Sintilimab plus Bevacizumab biosimilar IBI305 and chemotherapy as a first-line treatment in advanced gastric or gastroesophageal junction adenocarcinoma (SBAGA): a single-arm, phase Ib/II study

|
By Mo Cheng, Pengfei Zhang, Qiancheng Hu, Jitao Zhou, Ruihong Dai, Wenke Li, Jing Wei, Menghui Xu, Yanna Lei, Xiaoying Li, Xiufeng Zheng, Qian Huang, Zhiping Li, Bo Zhang, Wen Zhuang, Zhixin Chen, Xiaolong Chen, Chaoyong Shen, Weihan Zhang, Kai Liu, Linyong Zhao, Xiaonan Yin, Zhaolun Cai, Yuan Yin, Ji Chen, Chunjuan Liu, Deying Kang, Mojin Wang, Hongfeng Gou, Kun Yang, Jiankun Hu, Feng Bi, Ming Liu Verified, Boqiang Peng
| Nature Verified
Abstract Adding anti-PD-1 or anti-VEGF therapy to chemotherapy improves survival in patients with advanced gastric cancer, yet outcomes remain poor. This Phase Ib/II trial aimed to evaluate the efficacy and safety of combining sintilimab, the bevacizumab biosimilar IBI305, and CapeOX chemotherapy as a first-line treatment for patients with HER2-negative advanced gastric or gastroesophageal junction adenocarcinoma (GA/GEJA).
Open in Who Shared Issue with article?

Comparative efficacy of pulmonary rehabilitation delivery models on dyspnoea, exercise capacity and health-related quality of life in chronic respiratory disease: a systematic review and network meta-analysis | npj Primary Care Respiratory Medicine

|
By Deying Kang
| Nature Verified
Abstract This systematic review aimed to systematise the different models used to deliver pulmonary rehabilitation (PR) during chronic respiratory diseases (CRDs) and explore which ones are the most effective in terms of dyspnea, exercise capacity, and health-related quality of life (HRQoL). The literature search strategy involved structured searches of PubMed, Web of Science, and Cochrane Library for relevant articles published from January 2013 to March 2025.
Open in Who Shared Issue with article?

Frontiers | Treatment effects of fibrinogen concentrates vs. cryoprecipitate for correcting hypofibrinogenemia in cardiac surgery patients: a systematic review and meta-analysis

|
By Yue Chen, Wenjie Yang, Chongyang Zhao, Pengwei Ren, Xuemei Liu, Shuming Ji, Lei Chen, Deying Kang, Fujue Wang, Tingyong Cao
| Frontiers
SYSTEMATIC REVIEW article Volume 12 - 2025 | https://doi.org/10.3389/fcvm.2025.1671405 1 Introduction Excessive bleeding during cardiopulmonary bypass (CPB) remains a significant challenge in cardiac surgery and contributes to increased morbidity, mortality, and healthcare costs. Approximately 10% of patients undergoing cardiac surgery experience serious or massive bleeding, defined as chest tube output exceeding 1,000 ml within the first 12 h postoperatively (1–4).
Open in Who Shared Issue with article?
See all 4 articles